Proto Labs Inc
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $533.1M | $500.9M | $503.9M | $488.4M | $488.1M |
| Gross profit | $237.1M | $223.2M | $222.0M | $215.5M | $222.7M |
| Operating income | $25.1M | $19.9M | $28.2M | -$98.0M | $40.3M |
| Operating expenses | $212.0M | $203.3M | $193.8M | $313.4M | $182.3M |
| Cost of revenue | $296.0M | $277.7M | $281.9M | $272.9M | $265.4M |
| Cash from operations | $74.5M | $77.8M | $73.3M | $62.1M | $55.2M |
| Capital expenditure | $14.8M | $9.2M | $28.1M | $21.7M | $34.2M |
| Free cash flow | $59.7M | $68.7M | $45.2M | $40.4M | $21.0M |
| Share repurchases | $43.0M | $60.3M | $44.0M | $29.7M | $23.3M |
| Impairments | $0 | $0 | $0 | $118.0M | $0 |
| Total assets | $763.4M | $743.5M | $772.4M | $802.2M | $928.6M |
| Total liabilities | $89.5M | $73.4M | $77.1M | $104.5M | $100.1M |
Shares outstanding 23.8M · Free float 98.7%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.